Search

everythinglearnresearchcommunity

for

Search:↓

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

High serum DHT levels can help diagnose PCOS.

Lower Paraoxonase 1 levels in alopecia areata patients suggest antioxidant treatment might help.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

People with Alopecia Areata have lower vitamin D levels.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

PEG and keratin scaffolds can effectively deliver protein drugs by controlling release based on pH levels.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

PRP derivatives are likely safe for therapeutic use without harmful effects.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

COC treatment improves hormone and metabolic levels in PCOS patients.

Alopecia areata patients have higher hormone levels, suggesting hormonal screening could help in treatment.

Intralesional vitamin D3 injections can improve vitamin D3 levels and may help treat alopecia areata.

Insulin resistance is linked to higher hormone levels in women with PCOS.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.